WGS · XBRL financial data

GeneDx Holdings financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (WGS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	53	57*	62	71	77	96*	87	103	117	121*	102	114
Cost of goods and services sold	28	27*	25	28	29	29*	29	32	32	37*	34	36
Gross profit	25	31*	37	43	48	66*	58	71	85	84*	68	78
Research and development	14	12*	12	11	12	12*	13	15	20	25*	20	20
Selling, general and administrative	—	—	—	—	—	—	50	47	—	—	75	76
General and administrative	26	27*	22	25	26	27*	32	27	44	47*	—	—
Other operating income (expense)	(3)	(2)*	(1)	(1)	(1)	(1)*	—	—	—	year only	—	—
Operating income (loss)	(43)	(26)*	(14)	(11)	(8)	9*	(5)	9	(3)	(14)*	(57)	(17)
Other income (expense)	(1)	(0)*	0	(13)	1	(1)*	0	0	(0)	(5)*	(0)	0
Income tax expense (benefit)	(0)	(0)*	(0)	(0)	(0)	(0)*	0	(0)	0	(1)*	1	(1)
Net income (loss)	(42)	(26)*	(20)	(29)	(8)	5*	(7)	11	(8)	(18)*	(63)	(18)
Earnings per share, basic USD per share	(1.64)	(1.00)*	(0.78)	(1.10)	(0.31)	0.20*	(0.23)	0.38	(0.27)	(0.61)*	(2.16)	(0.60)
Earnings per share, diluted USD per share	(1.64)	(1.00)*	(0.78)	(1.10)	(0.31)	0.20*	(0.23)	0.36	(0.27)	(0.63)*	(2.16)	(0.60)
Weighted average shares, basic millions of shares	26	26*	26	27	27	28*	28	29	29	29*	29	30
Weighted average shares, diluted millions of shares	26	26*	26	27	27	28*	28	30	29	28*	29	30

Fiscal quarters (WGS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	87	100	84	56	58	85	100	74	96	105	94	60
Marketable securities	27	30	29	51	59	56	59	60	59	66	77	72
Accounts receivable	—	—	—	—	—	38	46	48	61	74	77	84
Inventory	9	9	12	10	11	11	13	12	11	14	12	18
Prepaid and other current assets	16	11	10	19	20	9	8	10	11	9	11	12
Total current assets	172	182	163	162	186	198	226	205	238	268	271	246
Property and equipment, net	36	32	—	—	—	33	—	—	—	46	50	54
Right-of-use asset	28	27	26	26	25	26	25	25	24	23	35	34
Goodwill	—	—	—	—	—	0	—	13	13	14	2	2
Total assets	417	419	395	389	409	419	446	464	494	524	506	481
Accounts payable	15	10	9	8	9	8	16	4	3	2	11	5
Accrued liabilities	13	12	11	7	11	12	14	28	26	45	25	30
Current portion of long-term debt	0	0	1	1	1	1	1	1	1	5	0	0
Total current liabilities	68	59	51	68	77	55	70	71	88	109	88	75
Long-term debt	6	53	52	52	52	52	52	52	52	48	97	97
Lease liability, non-current	—	44	—	—	—	43	—	—	—	39	—	—
Total liabilities	163	191	187	195	204	174	189	187	202	216	252	237
Accumulated deficit	(1,274)	(1,300)	(1,320)	(1,350)	(1,358)	(1,352)	(1,359)	(1,348)	(1,356)	(1,373)	(1,437)	(1,455)
Total stockholders' equity	254	228	207	194	205	245	257	277	292	308	254	244
Total liabilities and equity	417	419	395	389	409	419	446	464	494	524	506	481
Common shares outstanding (cover page) millions of shares	26	26	26	27	27	28	29	29	29	29	30	30

Fiscal quarters (WGS's year ends in late December)

In millions of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(42)	(26)*	(20)	(29)	(8)	5*	(7)	11	(8)	(18)*	(63)	(18)
Stock-based compensation	0*	(1)*	(0)	3*	4*	3*	4	8*	11*	10*	9	6*
Depreciation and amortization	5	3*	2	2	2	2*	2	2	2	3*	3	3
Net cash from operating activities	(41)*	(30)*	(16)	(5)*	(4)*	(3)*	10	10*	16*	(3)*	(32)	(29)*
Purchases of property and equipment	0*	2*	0	1*	1*	3*	6	2*	6*	4*	6	10*
Net cash from investing activities	(27)*	(5)*	1	(23)*	(8)*	(1)*	(9)	(36)*	(5)*	(11)*	(17)	(6)*
Proceeds from issuing common stock	—	—	—	—	—	—	0	0*	—	—	0	0*
Proceeds from long-term debt	—	year only	—	—	—	year only	—	—	—	year only	—	—
Net cash from financing activities	(1)*	47*	(0)	(0)*	14*	31*	14	0*	11*	23*	39	1*
Net change in cash	(69)*	12*	(16)	(28)*	2*	27*	14	(26)*	22*	9*	(11)	(34)*

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
GeneDx Holdings	60	114	(29)*	29.8M	4.6 quarters	Q2 FY26 10-QJun 30, 2026
Privia Health Group	412	not reported	1.1*	127.7M	—	Q2 FY26 10-QJun 30, 2026
Omada Health	222	88	4*	61.2M	—	Q2 FY26 10-QJun 30, 2026
Pennant Group	15	298	22*	34.9M	—	Q2 FY26 10-QJun 30, 2026
LifeStance Health Group	226	435	100*	382.1M	—	Q2 FY26 10-QJun 30, 2026
U S Physical Therapy	25	214	34*	14.9M	—	Q2 FY26 10-QJun 30, 2026
Talkspace	39	62	11*	165.8M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.